| No headlines available for PHLAX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
388.44M |
| Category: |
Specialty-Health |
| Total Expense Ratio: |
1.19% |
|
| PERFORMANCE & RISK | 31-Dec-07
| YTD Return: |
16.99% |
| 5y Avg Return: |
23.36% |
| Rank in Category (ytd): |
38 |
| % Rank in Category (ytd): |
18.91% |
| Beta (3y): |
0.85 |
| Morningstar Risk Rating: |
Above average |
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of investable assets in equity and equity-related securities of companies in the banking and financial services group of industries. It may invest more than 5% of assets in any one issuer. The fund may invest in ADRs and S&P Depositary Receipts, REITs, warrants and rights. It may participate in the IPO market. The fund may also invest up to 35% of total assets in foreign securities (excluding ADRs, ADSs, or similar receipts and shares traded in U.S. markets). It is nondiversified. |
|
| Fund Profile |
|
Help
0.14 (0.73%) 
Summary
Add PHLAX to Portfolio 
Download Data
